🟢 RBLX is trading 8% up today as analysts hike price targets following a massive Q4 bookings beat

RBLX is trading at $72.07 (+8.51%) as the stock extends gains from its strong Q4 2025 earnings report.

• Bookings reached $2.22B (+63% YoY), surpassing analyst estimates by $150M.
• Roth/MKM upgraded the stock to Buy with an $84 price target, citing robust 2026 guidance.
• The stock is significantly outperforming a flat Nasdaq, despite some caution from Benchmark regarding AI competition.